Clinical Trial Update: Sequential T and I With H101 Via HAI for BCLC C Stage HCC: A Prospective Single-Center Single-Arm Pilot Study [Phase 2]

View source ↗

Summary

A prospective, single-center, single-arm Phase 2 pilot study evaluating sequential T and I with H101 delivered by hepatic arterial infusion for BCLC C hepatocel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• H101 (oncolytic adenovirus H101)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Hepatocellular Carcinoma (HCC) | Phase 2 | Status: NOT_YET_RECRUITING